Merck’s diabetes drugs could contain carcinogen, FDA warns

The FDA said Aug. 9 tests of samples of a Merck diabetes drug detected substances that can cause cancer, and to avoid shortages, the department said it would allow increased levels of the carcinogen by nearly 150 percent.